Age, gender, social deprivation, smoking independently linked to pactiveRA, as well as depression, lung disease, gastric ulcers
MONDAY, July 22, 2024 (HealthDay News) — Socioeconomic factors and deprivation are associated with persistently active rheumatoid arthritis (pactiveRA), according to a study published online July 14 in RMD Open.
Maryam Adas, from the King”s College London Faculty of Life Sciences & Medicine, and colleagues examined which biological and nonbiological factors are associated with pactiveRA or persistently low RA (plowRA) (682 and 1,026 patients, respectively).
The researchers found that patients with pactiveRA were younger than those with plowRA (58 versus 62 years), and more were women (69 versus 59 percent). In patient-reported outcomes at baseline and anxiety and depression screens, pactiveRA was associated with worse scores. Overall, clear social patterning was seen in pactiveRA, with age-by-gender interaction. After controlling for disease severity markers, independent associations were seen for age, gender, social deprivation, and previous or current smoking with pactiveRA. Associations with pactiveRA were also seen for depression, lung disease, gastric ulcers, and baseline corticosteroid use.
“Identifying “adverse” socioeconomic factors that could drive persistently active disease following diagnosis can help risk-stratify patients and tailor interventions according to individual characteristics and needs,” the authors write.
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder
Exposure to Air Pollutants Linked to Increased RA Disease Activity
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA
Consensus Statements Developed for Rheumatoid Arthritis-Linked Interstitial Lung Disease
Bimekizumab Well Tolerated, Efficacious Over Three Years in Axial Spondyloarthritis
Longer Persistence Seen With Upadacitinib Versus TNFi in Rheumatoid Arthritis